Cargando…
A review of Dynamin 2 involvement in cancers highlights a promising therapeutic target
Dynamin 2 (DNM2) is an ubiquitously expressed large GTPase well known for its role in vesicle formation in endocytosis and intracellular membrane trafficking also acting as a regulator of cytoskeletons. During the last two decades, DNM2 involvement, through mutations or overexpression, emerged in an...
Autores principales: | Trochet, Delphine, Bitoun, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296698/ https://www.ncbi.nlm.nih.gov/pubmed/34294140 http://dx.doi.org/10.1186/s13046-021-02045-y |
Ejemplares similares
-
Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicing
por: Trochet, Delphine, et al.
Publicado: (2016) -
Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutations
por: Dudhal, Swati, et al.
Publicado: (2022) -
Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy
por: Trochet, Delphine, et al.
Publicado: (2022) -
Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy
por: Trochet, Delphine, et al.
Publicado: (2017) -
Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathy
por: Fraysse, Bodvaël, et al.
Publicado: (2016)